Ashlyn Everett, MD
Radiation Oncology · Huntsville, ALNPI 1780063370
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Siemens Medical Solutions USA, Inc. accounts for 91.6% of it on its own, with 8 other manufacturers making up the rest.
Across 27 payments — averaging $228.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$6K
- Brainlab, Inc.$153
- E.r. Squibb & Sons, L.L.C.$127
- Novocure Inc.$88
- Boston Scientific$74
- Sumitomo Pharma America, Inc.$24
- plus $52 from 3 others
What the payments were for
- Consulting fees$2,95348%
- Speaking & faculty fees$2,00032%
- Travel & lodging$1272%
- Food & beverage$1,08918%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 12 | $5,652 |
| Brainlab, Inc. | 2 | $153 |
| E.r. Squibb & Sons, L.L.C. | 2 | $127 |
| Novocure Inc. | 4 | $88 |
| Boston Scientific | 3 | $74 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Merck | 1 | $17 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,170 in reported general payments places this provider in the 85th percentile of 87 radiation oncology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 21 | $720 |
| Sucralfate | 24 | $565 |
| Tamsulosin Hcl | 41 | $370 |
| Dexamethasone | 15 | $362 |
| Lidocaine Hcl ViscousLidocaine Hcl | 31 | $270 |
| Prochlorperazine Maleate | 11 | $244 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $192 |
| Oxybutynin Chloride | 18 | $184 |
| Methylprednisolone | 17 | $156 |
| Fluconazole | 16 | $102 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $95 |
| Gabapentin | 12 | $75 |
| Lorazepam | 24 | $18 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Huntsville
- John GleasonHuntsville$9K
- Hoyt ChildsHuntsville$7K
- Harry McCartyHuntsville$6K
- Elizabeth FalkenbergHuntsville$971
- Alexander WhitleyMontgomery$441K
- Drexell BoggsBirmingham$35K
- Christopher JahrausAlabaster$28K
- Christopher WilleyBirmingham$13K
- Adam KoleBirmingham$11K
- William HixsonFairhope$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.